- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Sep 16, 2022
84307930553384WIT-MF-000009277Certificate health across this manufacturer's portfolio.
V12 034483 0002Issued10 warnings recorded — scroll inside the panel to see all entries.
CW010CW083CW105CW165CW167CW306CW166CW226CW999CW129Primary placement in Italy; available across 17 countries total.
| Country | On market since | Until |
|---|---|---|
| ItalyPrimary placement | Sep 16, 2022 | Still on market |
| Austria | Sep 16, 2022 | Still on market |
| Belgium | Sep 16, 2022 | Still on market |
| Cyprus | Sep 16, 2022 | Still on market |
| Germany | Sep 16, 2022 | Still on market |
| EL | Sep 16, 2022 | Still on market |
| Spain | Sep 16, 2022 | Still on market |
| Croatia | Sep 16, 2022 | Still on market |
| Ireland | Sep 16, 2022 | Still on market |
| Liechtenstein | Sep 16, 2022 | Still on market |
| Lithuania | Sep 16, 2022 | Still on market |
| Luxembourg | Sep 16, 2022 | Still on market |
| Malta | Sep 16, 2022 | Still on market |
| Netherlands | Sep 16, 2022 | Still on market |
| Poland | Sep 16, 2022 | Still on market |
| Romania | Sep 16, 2022 | Still on market |
| XI | Sep 16, 2022 | Still on market |
European Medical Device Nomenclature — the EU product classification assigned to this device.
W01010214GLYCOSYLATED/GLYCATED HAEMOGLOBIN (CC)